SCHEMBL24019644

SCHEMBL24019644

CCC(=O)c1cc2ccc(OC)cc2[nH]1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 8/20 0.63
PDGFRB P09619 4/20 0.63
PDGFRA P16234 3/20 0.63
NPC1 O15118 5/20 0.60
RAB9A P51151 5/20 0.60
KMT2A Q03164 4/20 0.60
PLG P00747 1/20 0.58
PLAU P00749 1/20 0.58
MEN1 O00255 2/20 0.57
RXFP1 Q9HBX9 1/20 0.57
HRH4 Q9H3N8 1/20 0.56
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.55
HPGD P15428 1/20 0.55
HTT P42858 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
MTNR1A P48039 1/20 0.54
MTNR1B P49286 1/20 0.54
HDAC1 Q13547 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5827810 0.88 PDGFRB (0.72) FLT3PDGFRBPDGFRANPC1RAB9A
SCHEMBL19676569 0.85 PLG (0.56) FLT3PDGFRBPDGFRANPC1RAB9A
SCHEMBL10003480 0.83 FLT3 (0.58) FLT3PDGFRBPDGFRANPC1RAB9A
SCHEMBL30189510 0.83 FLT3 (0.68) FLT3PDGFRBPDGFRANPC1RAB9A
SCHEMBL335655 0.83 FLT3 (0.68) FLT3PDGFRBPDGFRANPC1RAB9A
SCHEMBL24113306 0.83 FLT3 (0.68) FLT3PDGFRBPDGFRANPC1RAB9A
SCHEMBL1319990 0.82 RAB9A (0.80) FLT3PDGFRBPDGFRANPC1RAB9A
SCHEMBL3883246 0.81 FLT3 (0.67) FLT3PDGFRBPDGFRANPC1RAB9A
SCHEMBL216170 0.81 FLT3 (0.67) FLT3PDGFRBPDGFRANPC1RAB9A
SCHEMBL29368200 0.81 FLT3 (0.67) FLT3PDGFRBPDGFRANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11524940-B1 Inhibitors of cysteine proteases and methods of use thereof Pardes Biosciences, Inc. (US) 2022-12-13 US disclosed
US-11174231-B1 Inhibitors of cysteine proteases and methods of use thereof Pardes Biosciences, Inc. (US) 2021-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174231-B1 Inhibitors of cysteine proteases and methods of use thereof CTRL, CTSV, CTSL FLT3 2640/4885PDGFRB 3175/4885PDGFRA 3762/4885
US-11524940-B1 Inhibitors of cysteine proteases and methods of use thereof CTRL, CTSV, CTSL FLT3 2640/4885PDGFRB 3175/4885PDGFRA 3762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.